Krebs Biochemicals & Industries Overview
- Year Founded
-
1991
- Status
-
Public
- Employees
-
142
- Stock Symbol
-
524518
- Share Price
-
$0.63
- (As of Friday Closing)
Krebs Biochemicals & Industries General Information
Description
Krebs Biochemicals & Industries Ltd is engaged in the business of manufacture of active pharmaceutical ingredients. The company is operating in only one segment business of Pharma. Its products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, Phenylephrine, Androstenedione, Lovastatin, and Simvastatin.
Contact Information
Website
www.krebsbiochem.comCorporate Office
- Plot Number 34, 3rd Floor, Maas Heights
- Road Number 8, Banjara Hills
- Hyderabad, Telangana 500034
- India
Corporate Office
- Plot Number 34, 3rd Floor, Maas Heights
- Road Number 8, Banjara Hills
- Hyderabad, Telangana 500034
- India
Krebs Biochemicals & Industries Stock Performance
As of 13-Nov-2026, Krebs Biochemicals & Industries’s stock price is $0.63. Its current market cap is $13.5M with 21.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.63 | $0.63 | $0.41 - $0.85 | $13.5M | 21.6M | 4.03K | -$0.07 |
Krebs Biochemicals & Industries Financials Summary
As of 30-Sep-2026, Krebs Biochemicals & Industries has a trailing 12-month revenue of $2.9M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 41,628 | 32,449 | 39,368 | 38,067 |
| Revenue | 2,897 | 2,686 | 5,122 | 6,091 |
| EBITDA | 57 | (404) | (1,714) | (1,019) |
| Net Income | (1,440) | (1,916) | (3,186) | (2,383) |
| Total Assets | 16,531 | 17,302 | 19,761 | 21,366 |
| Total Debt | 23,632 | 28,599 | 30,069 | 28,620 |
Krebs Biochemicals & Industries Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Krebs Biochemicals & Industries Signals
Krebs Biochemicals & Industries Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Krebs Biochemicals & Industries ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Krebs Biochemicals & Industries FAQs
-
When was Krebs Biochemicals & Industries founded?
Krebs Biochemicals & Industries was founded in 1991.
-
Where is Krebs Biochemicals & Industries headquartered?
Krebs Biochemicals & Industries is headquartered in Hyderabad, India.
-
What is the size of Krebs Biochemicals & Industries?
Krebs Biochemicals & Industries has 142 total employees.
-
What industry is Krebs Biochemicals & Industries in?
Krebs Biochemicals & Industries’s primary industry is Pharmaceuticals.
-
Is Krebs Biochemicals & Industries a private or public company?
Krebs Biochemicals & Industries is a Public company.
-
What is Krebs Biochemicals & Industries’s stock symbol?
The ticker symbol for Krebs Biochemicals & Industries is 524518.
-
What is the current stock price of Krebs Biochemicals & Industries?
As of 13-Nov-2026 the stock price of Krebs Biochemicals & Industries is $0.63.
-
What is the current market cap of Krebs Biochemicals & Industries?
The current market capitalization of Krebs Biochemicals & Industries is $13.5M.
-
What is Krebs Biochemicals & Industries’s current revenue?
The trailing twelve month revenue for Krebs Biochemicals & Industries is $2.9M.
-
What is Krebs Biochemicals & Industries’s annual earnings per share (EPS)?
Krebs Biochemicals & Industries’s EPS for 12 months was -$0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process